CD274 and cancer: However, also taking this aspect into consideration, the improvement of anti-cancer therapies so far achieved by blocking PD-L1/PD-1 interaction in cancer patients remains partial, suggesting that more in-depth investigations on the regulation of these molecules is needed to optimize the treatment [3].